A look at top-selling food products presents concern about market awareness of potassium.
Potassium is a heart-healthy nutrient that appears to manage blood pressure and lower stroke risk. But researchers writing in JAMA Internal Medicine say few food manufacturers are listing potassium content on nutrition facts panels (NFPs).
Manufacturers are required to list sodium content on NFPs, but listing potassium is optional-and probably not encouraged enough. Opportunities to advertise high potassium levels are available for many foods, such as tomato juice, canned soups, and canned beans.
To assess the rate of potassium inclusion on NFPs across the United States, researchers gathered universal product codes (UPCs) for 6560 top-selling food products-from 61 food categories-sold at major U.S. retailers. Potassium content was listed for just 10% of all products. In nearly half of all food categories, potassium listings were present for less than 1% of products.
Even categories that could be expected to include potassium-rich products (e.g. canned tomatoes and beans) had a low rate of listing. The few categories in which potassium listings ran on more than half of products were vegetable juices; seasoned processed potatoes; instant hot cereal; French toast, pancakes, and waffles; and entrée sauces, such as spaghetti sauce.
Especially for consumers looking to lower their risk of heart disease or restrict their potassium intake, “The lack of potassium information on the NFP presents a problem for patients and consumers trying to make informed decisions when purchasing foods,” wrote the researchers. It also presents a problem for researchers and policy makers interested in understanding potassium’s role in the U.S. food supply.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.